达能一季报显示2025开局良好，健康产品组合优势显现

Group 1 - The core viewpoint of the articles highlights Danone's strong performance in Q1 2025, with a sales revenue of €6.844 billion, reflecting a year-on-year growth of 4.3% driven by both volume and pricing factors [1][2] - The CEO of Danone, Emmanuel Faber, emphasized the company's robust product portfolio and execution capabilities, which are expected to enhance business resilience despite current uncertainties [1] - The company reported significant regional performance, with North Asia and Oceania showing a 9.9% increase in sales revenue, while North America and Latin America also experienced growth of 3.7% and 9% respectively [1][2] Group 2 - In the professional special nutrition segment, sales revenue reached €2.306 billion, marking a year-on-year increase of 5.3%, driven by strong demand for infant formula and medical nutrition products [2] - The company aims to achieve a full-year sales revenue growth of 3% to 5% in 2025, aligning with its mid-term targets [3]